• 1. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 5. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Introduction to Tert-butyl 2-(4-amino-1H-pyrazol-1-yl)acetate (CAS No. 786684-63-7) in Modern Chemical and Pharmaceutical Research

Tert-butyl 2-(4-amino-1H-pyrazol-1-yl)acetate, identified by its Chemical Abstracts Service (CAS) number 786684-63-7, is a compound of significant interest in the realm of chemical and pharmaceutical research. This molecule, featuring a tert-butyl group and an amino-substituted pyrazole moiety, has garnered attention due to its versatile structural framework and potential applications in drug discovery and synthetic chemistry. The unique combination of functional groups in this compound makes it a valuable scaffold for developing novel therapeutic agents, particularly in the areas of anti-inflammatory, anticancer, and antimicrobial therapies.

The pyrazole core is a heterocyclic aromatic ring system that is widely recognized for its biological activity and structural stability. Pyrazole derivatives have been extensively studied for their pharmacological properties, with numerous compounds entering clinical trials for various diseases. The presence of an amino group at the 4-position of the pyrazole ring further enhances the compound's reactivity, allowing for diverse chemical modifications and functionalization. This feature is particularly useful in medicinal chemistry, where selective derivatization can lead to the identification of high-affinity ligands for specific biological targets.

The tert-butyl acetate moiety contributes to the overall solubility and stability of the compound, making it suitable for both in vitro and in vivo studies. The tert-butyl group, being a bulky alkyl substituent, can influence the pharmacokinetic properties of the molecule by affecting its metabolic pathways and binding affinity to biological receptors. This structural characteristic is often exploited in drug design to optimize pharmacological activity while minimizing off-target effects.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the biological activity of Tert-butyl 2-(4-amino-1H-pyrazol-1-yl)acetate with greater accuracy. Studies have shown that this compound exhibits promising interactions with various enzymes and receptors, suggesting its potential as a lead compound for drug development. For instance, computational simulations indicate that the amino-substituted pyrazole ring can form hydrogen bonds with key residues in protein targets, thereby modulating their function. Such insights are crucial for designing structure-based drugs that exhibit high specificity and efficacy.

In addition to its theoretical potential, experimental studies have begun to explore the pharmacological effects of Tert-butyl 2-(4-amino-1H-pyrazol-1-yl)acetate. Preliminary findings suggest that this compound demonstrates inhibitory activity against certain inflammatory pathways, making it a candidate for treating chronic inflammatory diseases. The ability of the pyrazole moiety to interact with cytokine receptors and signaling molecules has been highlighted as a key mechanism underlying its therapeutic effects. Furthermore, the tert-butyl group may contribute to reducing toxicity by stabilizing the molecule against rapid degradation.

The synthetic route to Tert-butyl 2-(4-amino-1H-pyrazol-1-yl)acetate is another area of active research. Efficient synthetic methodologies are essential for producing this compound on a scalable basis, ensuring its availability for further biological testing. Modern synthetic techniques, such as transition metal-catalyzed cross-coupling reactions and microwave-assisted synthesis, have been employed to streamline the preparation process. These methods not only improve yield but also minimize waste generation, aligning with green chemistry principles.

The role of Tert-butyl 2-(4-amino-1H-pyrazol-1-yl)acetate in combinatorial chemistry and library screening is also noteworthy. Its structural features make it an ideal building block for generating diverse chemical libraries, which can be screened for novel bioactive compounds. High-throughput screening (HTS) technologies have been utilized to identify derivatives of this molecule with enhanced pharmacological properties. Such approaches accelerate the drug discovery process by enabling rapid evaluation of large numbers of compounds.

Future directions in research may focus on exploring the metabolic fate of Tert-butyl 2-(4-amino-1H-pyrazol-1-yl)acetate in vivo. Understanding how this compound is processed by biological systems can provide critical insights into its safety profile and duration of action. Metabolomic studies may reveal key enzymatic pathways involved in its degradation, guiding modifications to improve bioavailability and reduce potential side effects.

In conclusion, Tert-butyl 2-(4-amino-1H-pyrazol-1-yl)acetate (CAS No. 786684-63-7) represents a promising candidate for further exploration in pharmaceutical research. Its unique structural features, combined with recent advancements in computational modeling and synthetic chemistry, position it as a valuable tool for developing novel therapeutic agents. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in addressing unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)